# Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).

> **NCT01750060** · PHASE1 · COMPLETED · sponsor: **Incline Therapeutics, Inc.** · enrollment: 54 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT01750060
- **Lead sponsor:** Incline Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2013-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750060, "Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01750060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*